Skip to main content

Table 1 Correlation between MYO18B expression and clinical characteristics in patients with hepatocellular carcinoma

From: MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway

Characteristics Expression of MYO18B P value
Low High
Age    0.361
 < 60 18 14  
 ≥ 60 22 26  
Gender    0.260
 Female 20 15  
 male 20 25  
Grade    1.000
 G1 + G2 26 26  
 G3 + G4 14 14  
Pathologic-Stage    0.025
 I + II 24 14  
 III + IV 16 26  
Pathologic-T    0.014
 T1 + T2 26 15  
 T3 + T4 14 25  
Pathologic-N    1.000
 N0 37 36  
 N1 3 4  
Pathologic-M    1.000
 M0 39 38  
 M1 1 2  
  1. T tumor status, N regional lymph node status, M metastasis status